Delegate Connector login

More information

Home

General Information

Registration & Accommodation

Abstracts

Organisation

Conference Programme

Scholarship Programme

Satellite Symposia

Conference Exhibition

Tours & Transportation

Local Volunteers

Poster Exhibition

Wednesday, 27 July 2005

Abstract Categories	Number of abstracts in this category
3.1 PK and pharmacodynamics	1
3.2 Pharmacological monitoring of ARV therapy	13
3.3 Drug interactions	18
4.1 Resistance surveillance	23
4.4 Resistance testing in clinical practice	22
6.2 Clinical trials of new drugs/pro-drugs	5
6.3 Phase III/IV trials	15
8.1 T-cell homeostasis	5
8.10 Disease progression	8
8.11 Biomarkers for HIV disease	4
8.12 Targets of HIV infection	6
8.13 Viral compartments and reservoirs	4
8.3 Biology of transmission	1
8.4 Primary infection	4
8.5 Dendric cells in HIV pathogenesis	3
8.6 Cytokines in HIV pathogenesis	6
8.8 Anatomical and cellular reservoirs	4
8.9 Host genetic factors	8
9.2 Paediatric treatment strategies	2
10.3 Post-exposure prophylaxis	12
10.4 Harm reduction and IDU-related strategies	18
10.5 Occupational transmission	9
10.6 Blood safety	1
10.8 Microbicides	7
11.3 Prices of drugs	7
11.5 Cost-benefit of HAART	4
12.1 Treatment of primary HIV infection	5
12.2 Initiation of therapy	29
12.3 Treatment simplification	22
12.4 Treatment interruption	14
12.5 Treatment of HIV-2	1
12.6 Resistance testing in clinical practice	5
12.7 Adherence	39
12.8 Immune therapy	6
12.9 Treatment failure and salvage therapy	22
13.13 Planning for vaccine efficacy trials	12
13.9 Clinical trials	1
16.1 HIV-induced immune dysfunction and activation	3
16.2 Cellular suppressive factors	1
16.3 Innate immunity	8
16.4 HIV-specific humoral immunity	2
16.5 HIV-specific cellular immunity	7
16.6 HIV-specific mucosal immunity	2
16.7 Immune reconstitution	11
16.8 Viral escape and immune pressure	3
16.9 Long-term nonprogressors and HIV-2 infection	1
17.1 Viral entry	1

Back